Ex-Insys Staffer Denied Bid To Use Marijuana Pre-Trial

Law360, New York (July 10, 2017, 6:45 PM EDT) -- A Connecticut magistrate judge said Friday a former Insys Therapeutics Inc. sales manager charged with participating in a scheme to steer kickbacks to doctors who prescribed a spray version of the opioid fentanyl can’t use prescription marijuana while awaiting a November trial.

U.S. Magistrate Judge Sarah A. L. Merriam denied Jeffrey Pearlman’s bid to remove drug testing from his bail conditions, calling it necessary to ensure compliance with federal law and the safety of the community. Pearlman said he used medical marijuana to stem his reliance on opioids to reduce pain from a spinal injury he suffered in a car accident...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Law Firms

Government Agencies